While ketamine produces a whole symphony of effects in the brain, surprisingly, a localized neural oscillation in a lesser-known area of the brain is enough to cause feelings of dissociation.
Both have long-lasting positive effects on mood, social skills and neuroplasticity. Combining them may potentiate and prolong mutual therapeutic effects.
This study provides the first preliminary quantitative exploration of the psychological effects of psychedelics in individuals with a self-reported diagnosis of an eating disorder.
Research suggests that BDNF can help rewire and overwrite stubborn neural pathways by creating new connections that facilitate more flexible and adaptive thoughts and behaviours. Psychedelics appear to tap into this mechanism.
Harnessing the theoretical and technical synergy between Acceptance & Commitment Therapy (ACT) and Psilocybin-Assisted Psychotherapy (PcbAP)
THC binding to 5-HT2A may activate signaling pathways that cause negative effects on cognition and memory.
In the wake of Covid-19, psychedelic-assisted therapy is gaining attention.
Measuring and increasing post-traumatic growth may lead to more rewarding interpersonal relationships, self-esteem, and a more optimistic outlook on life.
Research indicates that ayahuasca promotes sustained decreases in neuroticism and increases in agreeableness and openness.
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.